News
Tack on a half-dozen zeros to your CVS receipt and you'll get a sense of the sticker shock afflicting state officials, insurers and hospitals dealing with the soaring cost of prescription drugs in ...
In a release on Tuesday, Novo Nordisk cut its expected full-year sales growth to 8%-14%, down from the 13%-21% it had expected to see as of May. The company also said it now expec ...
Cosmetic surgeons are reporting a growing number of patients with sagging skin and facial hollowing after losing weight with ...
More than 60 billion euros (£52 billion) has been wiped off the stock market value of Ozempic and Wegovy weight loss drug firm Novo Nordisk after it warned over sales and profits ...
By Meher Ahmad and Jessica Grose Produced by Derek Arthur Conservative Christian influencers are reshaping beauty standards ...
Momentum on MSN2hOpinion
Dropping The HammerForensics expert analysis of Jeffrey Epstein jail video contradicts government's claims Ozempic maker crashes as it loses ...
Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...
The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.
Trump’s trade deal with the E.U. may lead to higher prices for brand-name drugs in the U.S., including Ozempic and Wegovy, ...
Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...
Novo Nordisk stock (NVO) (DK:NOVO.B) slumped 21.83% to fall to a new three-year low. It was the stock's worst daily loss since a 26.15% fall on Oct. 19, 1987. It's fallen 24.77% over the past two days ...
Novo Nordisk A/S shares plunged after a Q2 revenue update and 2025 guidance downgrade. Click here to find out why NVO stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results